Prognostic Value of Early Postoperative Troponin T in Patients Undergoing Coronary Artery Bypass Grafting

Brigitta Gahl1, Volkhard Göber1, Ayodele Odutayo2

  • 1Department for Cardiovascular Surgery, Inselspital, Bern University Hospital University of Bern, Switzerland.

Insights

Post-coronary artery bypass grafting, elevated cardiac troponin T (cTnT) levels 6-12 hours after surgery predict major adverse cardiac or cerebrovascular events (MACCE). This finding aids in identifying high-risk patients for better outcomes.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Biomarkers

Background:

  • Cardiac troponin T (cTnT) levels rise after coronary artery bypass grafting (CABG) surgery.
  • The clinical significance of these elevations for in-hospital outcomes requires further investigation.

Purpose of the Study:

  • To determine the association between cTnT levels 6-12 hours post-CABG and in-hospital outcomes.
  • To evaluate the prognostic performance of both conventional and high-sensitivity cTnT (hs-cTnT) assays.

Main Methods:

  • Prospective study of 1722 patients undergoing isolated CABG.
  • Assessed conventional cTnT (749 patients) and hs-cTnT (973 patients) 6-12 hours postoperatively.
  • Evaluated major adverse cardiac or cerebrovascular events (MACCE) and a composite safety outcome.

Main Results:

  • Elevated cTnT levels were associated with increased odds of MACCE and safety composite events.
  • Both conventional and hs-cTnT showed moderate discrimination for MACCE and safety outcomes.
  • A cTnT cutoff of 800 ng/L demonstrated clinical relevance for ruling in adverse events.

Conclusions:

  • Postoperative cTnT levels measured 6-12 hours after CABG are valuable predictors of MACCE and other complications.
  • These findings support the use of cTnT as a prognostic marker in the early postoperative period following CABG.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
540
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
425
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
303
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
424
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
735